U.S. Communications Stock News

NYSE:MMI
NYSE:MMIReal Estate

How Investors Are Reacting To Marcus & Millichap (MMI) Q4 Profit, Full-Year Loss and Buyback Completion

In February 2026, Marcus & Millichap, Inc. reported fourth-quarter 2025 revenue of US$243.95 million and net income of US$13.31 million, alongside full-year 2025 revenue of US$755.16 million and a net loss of US$1.91 million, while also disclosing that it completed a share repurchase program totaling 3,146,936 shares for US$98.00 million. These results show improved quarterly profitability and a smaller full-year loss compared with the prior year, while the completed buyback reduced the...
NYSE:GIC
NYSE:GICTrade Distributors

Is It Time To Reassess Global Industrial (GIC) After Its Strong 1 Year Share Price Run

Are you wondering if Global Industrial still offers good value after its recent run, or if the current price already reflects the key positives for the business? The stock last closed at US$33.26, with returns of 4.3% over 7 days, 9.9% over 30 days, 13.1% year to date, 48.4% over 1 year, 32.6% over 3 years and 10.4% over 5 years. This naturally raises questions about what is now priced in. Recent coverage has focused on Global Industrial's role as a distributor of industrial and business...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Explores Solriamfetol In Phase 3 CLARITY Trial For MDD Subset

Axsome Therapeutics (NasdaqGM: AXSM) has started the CLARITY Phase 3 trial of solriamfetol in major depressive disorder with excessive daytime sleepiness. The trial focuses on a group of MDD patients who experience excessive daytime sleepiness, for which no approved treatments are currently available. This study expands Axsome's clinical program into an area of unmet medical need. Axsome Therapeutics, listed on the NasdaqGM under the ticker AXSM, develops therapies for central nervous...
NYSE:SPXC
NYSE:SPXCMachinery

SPX Technologies Reshapes Business With Deals Earnings And Shifting Ownership

SPX Technologies is pursuing an acquisition-led expansion and investing heavily in capacity, including in data center infrastructure. The company recently reported record earnings that align with this repositioning of its business mix. At the same time, insider selling and shifts in institutional ownership are reshaping who holds NYSE:SPXC shares. For investors, this mix of corporate activity and ownership changes makes NYSE:SPXC a stock to watch. The shares recently closed at $231.59, with...
NasdaqGS:PZZA
NasdaqGS:PZZAHospitality

Papa Johns International PZZA Margin Compression Reinforces Bearish Cost Narrative In FY 2025 Results

Papa John's International FY 2025 Earnings Snapshot Papa John's International (PZZA) closed out FY 2025 with Q4 revenue of US$498.2 million and basic EPS of US$0.24, while trailing twelve month revenue came in at about US$2.1 billion with EPS of US$0.93. The company has seen quarterly revenue move from US$530.8 million in Q4 2024 to US$498.2 million in Q4 2025, with basic EPS shifting from US$0.45 to US$0.24 over the same period, and trailing net income excluding extra items sitting at...
NYSE:MCB
NYSE:MCBBanks

A Look At Metropolitan Bank Holding (MCB) Valuation After Recent Follow On Equity Offerings

Metropolitan Bank Holding (MCB) has completed and filed follow-on equity offerings totaling roughly US$353.5 million, issuing 2,100,000 common shares at US$85, a move that directly affects existing and prospective shareholders. See our latest analysis for Metropolitan Bank Holding. The follow on offerings come after a strong 1 year total shareholder return of 41.92% and a 3 year total shareholder return of 56.43%. However, recent momentum has cooled, with a 7 day share price return showing an...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Is It Time To Reassess Natera (NTRA) After Strong Multi Year Share Price Gains

If you are wondering whether Natera's current share price reflects its real value, you are not alone. This article will help you frame that question clearly. Natera's share price last closed at US$216.10, with a 7 day return of 0.1% decline, a 30 day return of 10.1% decline, a year to date return of 5.6% decline, and a 1 year return of 38.0%, alongside a very large 3 year return and a 111.6% return over 5 years. Recent headlines around Natera have kept the stock on many investors'...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Magnite (MGNI) Net Margin Surge Challenges Bearish Earnings Narratives

Magnite (MGNI) closed out FY 2025 with Q4 revenue of US$205.4 million and basic EPS of US$0.86, capped by trailing 12 month EPS of US$1.01 that sits on trailing 12 month revenue of US$714.0 million. Over the past six quarters in this dataset, revenue has moved from US$162.0 million in Q3 2024 to US$205.4 million in Q4 2025, while quarterly EPS shifted from US$0.04 to US$0.86, creating a backdrop where margins have become a central focus for investors assessing the latest print. See our full...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

What Futu Holdings (FUTU)'s Q4 2025 Results and Education Push Mean For Shareholders

Earlier in 2026, Futu Holdings announced that it would report its fourth-quarter and full-year 2025 results on March 12, 2026, before U.S. markets open, accompanied by a management earnings call and webcast. Alongside its earnings timetable, Futu’s moomoo platform has been promoting financial education through initiatives like the Student Stock Showdown, underscoring how its brokerage technology is also being used to build investing literacy among younger users. With stronger recent earnings...
NYSE:WSO
NYSE:WSOTrade Distributors

Dividend Hike Amid Softer Earnings Might Change The Case For Investing In Watsco (WSO)

In February 2026, Watsco, Inc. reported that its fourth-quarter 2025 sales fell to US$1,578.76 million and net income to US$71.75 million, and also approved a 10% increase in its annual dividend to US$13.20 per share for both Common and Class B shares. The combination of softer recent earnings and a higher dividend, underpinned by management’s emphasis on improved gross margins and a debt-free balance sheet, highlights how Watsco is prioritizing shareholder returns while contending with...
NYSE:BAP
NYSE:BAPBanks

Is It Time To Reassess Credicorp (NYSE:BAP) After Its Strong Multi Year Share Price Run?

If you are looking at Credicorp and wondering whether the current share price still reflects solid value, you are not alone. This article will walk through what the numbers actually say. The stock last closed at US$355.48, with returns of 1.7% over 7 days, a marginal 0.2% decline over 30 days, 24.1% year to date, 106.7% over 1 year and 183.7% over 5 years. This naturally raises questions about how much future upside or risk is already built in. Recent news coverage has focused on Credicorp's...
NYSE:ARLO
NYSE:ARLOElectronic

A Look At Arlo Technologies (ARLO) Valuation After Recent Share Price Volatility

Arlo Technologies (ARLO) has drawn fresh attention after recent trading left the stock up 3.6% over the past week, but down over the past month and past 3 months, prompting closer scrutiny from investors. See our latest analysis for Arlo Technologies. That recent 6.2% 7 day share price return comes after weaker momentum earlier in the year, with a 30 day share price return of 6.52% and year to date share price return of 6.73%. The 3 year total shareholder return is roughly 3.3x, which hints...
NasdaqGS:PCTY
NasdaqGS:PCTYProfessional Services

A Look At Paylocity (PCTY) Valuation After Q2 Beat And Raised 2026 Revenue Outlook

Paylocity Holding (PCTY) is in focus after second quarter results came in ahead of guidance, prompting higher revenue projections for fiscal 2026 and an updated outlook for total and recurring revenues. See our latest analysis for Paylocity Holding. The second quarter beat and upgraded fiscal 2026 revenue outlook arrive after a mixed share price run, with an 8.52% 1 day share price return and 6.59% 7 day share price return contrasting with a 19.95% 30 day share price decline and a 44.87% 1...
NYSE:YETI
NYSE:YETILeisure

Did YETI’s New CFO, Buybacks, and 2026 Guidance Just Shift YETI Holdings’ (YETI) Investment Narrative?

Earlier in February 2026, YETI Holdings appointed former Home Depot finance executive Scott Bomar as its new Chief Financial Officer, reported fourth-quarter and full-year 2025 results showing higher quarterly sales and earnings, issued 2026 sales growth guidance of 6% to 8%, and completed a US$497.72 million share repurchase program. These announcements highlight YETI’s focus on leadership refresh, disciplined capital returns through buybacks, and continued investment in product innovation...
NasdaqGS:BCPC
NasdaqGS:BCPCChemicals

Does Stronger 2025 EPS Growth Reshape the Bull Case for Balchem’s Profitability Story (BCPC)?

Balchem Corporation recently reported fourth-quarter 2025 sales of US$263.62 million and net income of US$39.23 million, with full-year 2025 sales of US$1.04 billion and net income of US$154.85 million, all higher than the prior year. The company also delivered higher diluted earnings per share from continuing operations for both the quarter and the full year, pointing to improved profitability alongside revenue growth. We will now examine how this earnings improvement, particularly the rise...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Rhythm Pharmaceuticals (RYTM) Posts Q4 Revenue Gain That Challenges Bearish Cash Burn Narrative

Rhythm Pharmaceuticals (RYTM) has wrapped up FY 2025 with Q4 revenue of US$57.3 million and a basic EPS loss of US$0.73, while trailing 12 month figures show total revenue of US$189.8 million and a basic EPS loss of US$3.11. Over recent quarters, the company has seen revenue move from US$41.8 million in Q4 2024 to US$57.3 million in Q4 2025, with basic EPS losses ranging between US$0.72 and US$0.82 per quarter. This sets up a story where revenue is building but margins remain under...
NYSE:JXN
NYSE:JXNDiversified Financial

Will Profit Squeeze Amid Record Annuity Sales and Heavy Buybacks Change Jackson Financial's (JXN) Narrative

In February 2026, Jackson Financial Inc. reported fourth-quarter 2025 revenue of US$1,988 million but swung to a net loss of US$204 million, while also increasing its common dividend, declaring a preferred dividend, and completing a large share repurchase program that retired just over 40% of its shares since 2021. Despite record retail annuity sales and continued capital returns, the sharp drop in yearly net income to US$27 million and a move from earnings per share to a loss per share have...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Priority Review For DTX401 Spurs Fresh Look At Valuation

Ultragenyx Pharmaceutical (NasdaqGS:RARE) announced that the US FDA has accepted its Biologics License Application for DTX401, a gene therapy for Glycogen Storage Disease Type Ia. The FDA has granted Priority Review to the application, signaling an expedited assessment timeline. If approved, DTX401 could become the first pharmacologic treatment option for people living with Glycogen Storage Disease Type Ia. For Ultragenyx, with a current share price of $23.04, this regulatory milestone...
NasdaqGS:OCFC
NasdaqGS:OCFCBanks

Is OceanFirst Financial (OCFC) Pricing Reflect Long Term Prospects After Recent Share Gains

If you are looking at OceanFirst Financial and wondering whether its current share price lines up with its underlying worth, you are asking the exact question this article is built to tackle. The stock last closed at US$19.04, with returns of 3.8% over the past 30 days, 6.7% year to date, and 12.8% over the past year. The 3 year and 5 year returns sit at a 5.6% decline and a 5.0% gain respectively. These share price moves sit against a backdrop of ongoing sector wide attention on US regional...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

Should CDW’s New Mixed Shelf and AI Push Require Action From CDW (CDW) Investors?

Earlier this week, CDW Corporation filed an omnibus mixed securities shelf registration covering common and preferred stock, depositary shares, warrants, debt securities, and various share purchase instruments, enhancing its flexibility to raise capital for operations and growth initiatives. This filing, combined with recent commentary highlighting CDW’s stronger-than-expected quarterly results and focus on higher-demand areas like cloud, cybersecurity, and AI, underscores how the company is...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

MarketAxess Taps New CTO And DirectBooks Link As Shares Track Fair Value

MarketAxess Holdings (NasdaqGS:MKTX) has appointed William Quan as Chief Technology Officer to lead its AI and technology modernization efforts. The company has also announced an integration with DirectBooks that is designed to streamline primary market workflows for its clients. MarketAxess runs an electronic trading platform focused on fixed income markets, connecting institutional investors and dealers in credit products. The arrival of William Quan as CTO brings a leader with experience...
NYSE:SMR
NYSE:SMRElectrical

NuScale Lawsuits And Fluor Exit Test Support For SMR Projects

Several class action lawsuits have been filed against NuScale Power (NYSE:SMR) alleging misrepresentations about key commercialization partner ENTRA1 Energy. Plaintiffs claim NuScale understated the risks tied to ENTRA1, as fresh details emerge about substantial payments and project delays. At the same time, NuScale received approval for a small modular reactor project in Romania and major shareholder Fluor announced plans to exit its position. NuScale Power, trading at $13.33, is facing a...
NasdaqGS:PNTG
NasdaqGS:PNTGHealthcare

Pennant Group (PNTG) EPS Stability Reinforces Bullish Earnings Growth Narrative

Pennant Group’s FY 2025 Earnings Set Up the Next Phase of the Story The Pennant Group (PNTG) closed FY 2025 with fourth quarter revenue of US$289.3 million and basic EPS of US$0.25, capping a trailing twelve month period where revenue reached US$947.7 million and EPS came in at US$0.86. Over the past six reported quarters, the company has seen revenue move from US$188.9 million in Q4 2024 to US$289.3 million in Q4 2025, while quarterly EPS ranged between US$0.17 and US$0.25. This leaves...
NYSE:BHE
NYSE:BHEElectronic

Has The Benchmark Electronics (BHE) Rally Outrun Its Earnings And Cash Flow Metrics?

If you are looking at Benchmark Electronics and wondering whether the current share price reflects its true worth, this article will walk through the key pieces you need to weigh that question up. The stock most recently closed at US$59.18, with returns of 3.2% over 7 days, 20.8% over 30 days, 34.8% year to date, 52.0% over 1 year and 163.2% over 3 years, so valuation now sits front and center for many investors. Recent coverage has focused on Benchmark Electronics as an established...